Search Orphan Drug Designations and Approvals
-
Generic Name: | immune globulin (human) |
---|---|
Date Designated: | 03/02/2010 |
Orphan Designation: | Treatment of Guillain-Barre syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Octapharma USA, Inc. 121 River Street Suite 1201 Hoboken, New Jersey 07030 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-